Mainz, Germany

Daniel Zucker

USPTO Granted Patents = 1 

 

 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Daniel Zucker

Introduction

Daniel Zucker, an inventive mind based in Mainz, Germany, has made a significant contribution to the field of medical science through his groundbreaking patent. With a focus on the delivery of RNA to targeted organs and cells, Zucker's work revolves around enhancing pharmaceutical formulations for effective administration.

Latest Patents

Zucker holds a patent that presents a formulation for the administration of RNA. This invention specifically addresses compositions incorporating polyplex formulations designed for delivering RNA following parenteral administration, particularly through intramuscular injections. The formulation consists of polyplex particles composed of single-stranded RNA complexed with polyalkyleneimine. It may encode relevant proteins, including pharmaceutically active proteins. The patent also includes the development of pharmaceutical products that utilize these RNA polyplex formulations intended for parenteral application to both humans and animals. Steps for manufacturing such products encompass processes like sterile filtration, freezing, and dehydration.

Career Highlights

Throughout his career, Daniel Zucker has made impactful strides while collaborating with leading companies. Notably, he has worked with BioNTech SE and the Translational Oncology at the Johannes Gutenberg University Mainz Non-Profit GmbH. His innovative approach and dedication to research are evident in these esteemed organizations where pioneering medical solutions are at the forefront of their missions.

Collaborations

Zucker has collaborated with notable individuals in his field, such as Ugur Sahin and Heinrich Haas. These partnerships reflect a commitment to advancing medical research and innovation, further solidifying his role as a key figure in the development of novel treatments through RNA technology.

Conclusion

In conclusion, Daniel Zucker exemplifies the spirit of innovation through his unique contributions to RNA delivery systems in pharmaceuticals. His patent and collaborative efforts mark significant milestones in the quest for effective medical treatments, impacting both human and animal health. As he continues to push the boundaries of medical science, Zucker remains a vital contributor to the field of pharmaceuticals and therapeutic innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…